Clinical Trials Browser

OTHER × Leukemia, Myeloid, Acute × merestinib × Clear all

NCT03125239 2020-06-30

Combination Merestinib and LY2874455 for Patients With Relapsed or Refractory Acute Myeloid Leukemia

Phase 1 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute